News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

New Albany Molecular Research, Inc. (AMRI) (AMRI)'s CEO Ready To Make His Mark, Eyes Competitors



2/13/2014 7:57:20 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Bill Marth is going shopping--and that says a lot about the turnaround happening at the company he runs, Albany Molecular Research Inc. At the start of this year, Marth and AMRI's co-founder Tom D'Ambra switched roles. Marth became president and CEO; D'Ambra became company chairman, the first time in AMRI's 23-year history that he isn't running the company. AMRI (Nasdaq: AMRI) is best-known for discovering the active ingredient in the allergy medication Allegra.

Help employers find you! Check out all the jobs and post your resume.

Read at News Release


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES